Genetic testing

Personalized medicine is the quintessential use of molecular biology tools in genetic diagnosis. It is based on the belief that many disease entities have a genetic basis, which can significantly affect the correct diagnosis of patients as well as the initiation of appropriate therapy. The application of molecular diagnostic methods in genetic testing and the use of modern testing equipment makes it possible to determine with high probability in the tested patient the determination of the risk of disease, to determine the hereditary genetic burden, and allows the development and introduction of appropriate methods of prevention or dedicated methods of treatment of a given disease entity.


What is thrombophilia?

Thrombophilia, also known as hypercoagulability, is a congenital (genetically determined) or acquired tendency to develop clots in veins and arteries. It is estimated that about one-third of thromboembolic events are caused by a genetic predisposition in the patient. One of the most common causes of congenital thrombophilias is the G20210A mutation in the F2 gene encoding prothrombin and the Leiden mutation in the F5 gene encoding coagulation factor V.

For what purpose is a genetic test performed?

This test is performed to determine whether a patient carries the hereditary G20210A mutation in the gene encoding prothorombin and the Leiden mutation in the F5 gene encoding coagulation factor V. These are the most common mutations associated with congenital hypercoagulability.

For whom is a genetic test recommended?

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

    I consent to the processing of my personal data by Śląski Park Technologii Medycznych Kardio-Med Silesia Sp. z o.o., 10C M. Curie-Skłodowskiej St., 41-800 Zabrze, KRS:0000396540, NIP:6482761515, Regon:242742607, as Data Controler in order to receive a response. I can withdraw my consent by submitting a statement to: The Data Controler has notified me that this consent does not affect the legality of the processing carried out on the basis of consent before its withdrawal.

    The information clause on the details of the processing is available here.

    Supporting partners: